Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Matthew Cox

Physician Assistant Knoxville, TN Physician Assistant

NPI 1003324674 CMS profile 10873080

280 Fort Sanders West Blvd Ste 101, Knoxville, TN 37922

Open in the dashboard

General payments

$2,577

164 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Cox of Knoxville, TN is reported in the CMS Open Payments database as having received $2,577 across 164 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $846 60
2024 General $677 44
2023 General $348 20
2022 General $289 19
2021 General $417 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Cox
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Matthew Cox were reported at $846. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Matthew Cox Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $417 $132 $37–$438 $132
2022 $289 $155 $48–$522 $149
2023 $348 $167 $52–$557 $160
2024 $677 $178 $55–$600 $164
2025 $846 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Novo Nordisk Inc $629 38 payments
  2. AstraZeneca Pharmaceuticals LP $313 18 payments
  3. Amgen Inc. $299 22 payments
  4. Pfizer Inc. $280 24 payments
  5. GlaxoSmithKline, LLC. $166 9 payments
  6. Lilly USA, LLC $137 10 payments
  7. Astellas Pharma US Inc $98 5 payments
  8. Xeris Pharmaceuticals, Inc. $92 3 payments
  9. Lundbeck LLC $79 4 payments
  10. Boston Scientific Corporation $60 4 payments
  11. Other $424 27 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,577 164 payments
Products named General payments · program years 2021–2025
  1. RYBELSUS $374 23 payments
  2. Ozempic $367 27 payments
  3. Otezla $255 19 payments
  4. NURTEC ODT $210 20 payments
  5. AIRSUPRA $168 11 payments
  6. SHINGRIX $166 9 payments
  7. Repatha Cardiology $160 10 payments
  8. ZAVZPRET $150 12 payments
  9. REPATHA Cardiovascular $139 12 payments
  10. MOUNJARO $122 9 payments
  11. Other $1,608 98 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 24 drugs

Part D claims

605

Median for Physician Assistant: 241

Drug cost

$5,389

Median for Physician Assistant: $4,110

Branded share of claims

4.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Synthroid Levothyroxine Sodium Brand 12 $894
Mirtazapine Generic 14 $586
Rosuvastatin Calcium Generic 33 $520
Levothyroxine Sodium Generic 62 $494
Atorvastatin Calcium Generic 45 $466
Lisinopril Generic 77 $298
Omeprazole Generic 13 $214
Propranolol Hcl Generic 14 $212
Trazodone Hcl Generic 14 $199
Amlodipine Besylate Generic 65 $184

The 10 drugs with the highest cost, of 24 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 76 billing codes

Paid by Medicare

$20,280

Of which drugs: $1,501

Medicare patients

154

Average age 72

Services billed

742

79 women, 75 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 66%
Arthritis 38%
Ischemic heart disease 24%
Depression 20%
Chronic kidney disease 19%
Diabetes 18%
Atrial fibrillation 18%
Cancer 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 19 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
AIRSUPRA
  • AstraZeneca Pharmaceuticals LP $91
$91 — —
Repatha
  • Amgen Inc. $87
$87 — —
Ozempic
  • Novo Nordisk Inc $58
$58 — —
Otezla
  • Amgen Inc. $58
$58 — —
RYBELSUS
  • Novo Nordisk Inc $51
$51 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 19 in the dashboard with a free account

Records

164 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record